Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Foulkes Cancer Genetics LDI, |
RCV001201141 | SCV001372187 | likely benign | not specified | 2019-07-01 | criteria provided, single submitter | curation | ACMG criteria met: PM2, BP4, BP7 |
Genetic Services Laboratory, |
RCV001201141 | SCV002071915 | uncertain significance | not specified | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002339497 | SCV002634741 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |